Remedy Robotics

United States · Healthtech · Hardware · AI

Remedy Robotics develops AI-enabled robotic systems for endovascular procedures, aiming to extend specialist cardiovascular care to more hospitals.

Product

Its N1 platform combines robotic intervention with preoperative imaging, case simulation and computer vision. The system is being designed for on-site, remote and autonomous operation.

Based in San Francisco, Remedy is advancing clinical trials and regulatory development with hospital partners. N1 remains an investigational device and is unavailable for commercial sale.

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series B$62MDCVC — LeadBlackbird — ParticipantBuild Collective — ParticipantDivergent Capital — ParticipantHostplus — ParticipantKdT Ventures — ParticipantSkip Capital — ParticipantUC Investments — Participant
Sourcesremedyrobotics.com ↗prnewswire.com ↗